http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109652528-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 |
filingDate | 2018-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2020-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2020-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-109652528-B |
titleOfInvention | Molecular marker for postmenopausal osteoporosis |
abstract | The invention discloses a molecular marker for postmenopausal osteoporosis, which is miRNA-760 and miRNA-6734-5 p. Experiments prove that the miRNA-760 and the miRNA-6734-5p are up-regulated in the osteoporosis patients, and meanwhile, the expression level of the miRNA is changed to influence osteogenic differentiation, so that the miRNA-760 and the miRNA-6734-5p can be used as diagnosis and treatment targets of osteoporosis, and the individual diagnosis and treatment of the osteoporosis patients are realized. |
priorityDate | 2018-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 241.